Frequently searched
↑ ↓ to move · Enter to open · Esc to closeSynonyms and typos are matched
Trial site
Active, not recruiting
SELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic Malformations
NCT06239480· Phase 3· Palvella Therapeutics, Inc.· Source
Site data: ClinicalTrials.govUpdated 12 Nov 2026
Report an error